Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Sebens S"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 38
Tytuł:
Epithelial and Mesenchymal-like Pancreatic Cancer Cells Exhibit Different Stem Cell Phenotypes Associated with Different Metastatic Propensities.
Autorzy:
Philipp LM; Institute for Experimental Cancer Research, Kiel University, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, 23562 Kiel, Germany.
Yesilyurt UU; Institute for Experimental Cancer Research, Kiel University, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, 23562 Kiel, Germany.
Surrow A; Institute for Experimental Cancer Research, Kiel University, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, 23562 Kiel, Germany.
Künstner A; Medical Systems Biology Group, Lübeck Institute of Experimental Dermatology, University of Lübeck, 23538 Lübeck, Germany.; Institute for Cardiogenetics, University of Lübeck, 23562 Lübeck, Germany.
Mehdorn AS; Department of General, Visceral-, Thoracic-, Transplantation- and Pediatric Surgery, UKSH, Campus Kiel, 24105 Kiel, Germany.
Hauser C; Department of General, Visceral-, Thoracic-, Transplantation- and Pediatric Surgery, UKSH, Campus Kiel, 24105 Kiel, Germany.
Gundlach JP; Department of General, Visceral-, Thoracic-, Transplantation- and Pediatric Surgery, UKSH, Campus Kiel, 24105 Kiel, Germany.
Will O; Molecular Imaging North Competence Center, Clinic of Radiology and Neuroradiology, Kiel University, UKSH, Campus Kiel, 24118 Kiel, Germany.
Hoffmann P; Institute for Experimental Cancer Research, Kiel University, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, 23562 Kiel, Germany.
Stahmer L; Institute for Experimental Cancer Research, Kiel University, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, 23562 Kiel, Germany.
Franzenburg S; Institute of Clinical Molecular Biology, Kiel University, 24118 Kiel, Germany.
Knaack H; Institute for Experimental Cancer Research, Kiel University, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, 23562 Kiel, Germany.; Academic Affairs Office, Hannover Medical School, 30625 Hannover, Germany.
Schumacher U; Department of Anatomy and Experimental Morphology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Busch H; Medical Systems Biology Group, Lübeck Institute of Experimental Dermatology, University of Lübeck, 23538 Lübeck, Germany.; Institute for Cardiogenetics, University of Lübeck, 23562 Lübeck, Germany.
Sebens S; Institute for Experimental Cancer Research, Kiel University, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, 23562 Kiel, Germany.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2024 Feb 06; Vol. 16 (4). Date of Electronic Publication: 2024 Feb 06.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Understanding and leveraging phenotypic plasticity during metastasis formation.
Autorzy:
Shah S; Department of Theoretical Biology, Max Planck Institute for Evolutionary Biology, August-Thienemann-Str. 2, 24306, Plön, Germany. .
Philipp LM; Institute for Experimental Cancer Research, Kiel University and University Hospital Schleswig-Holstein, Campus Kiel, Arnold-Heller-Str. 3, Building U30, Entrance 1, 24105, Kiel, Germany.
Giaimo S; Department of Theoretical Biology, Max Planck Institute for Evolutionary Biology, August-Thienemann-Str. 2, 24306, Plön, Germany.
Sebens S; Institute for Experimental Cancer Research, Kiel University and University Hospital Schleswig-Holstein, Campus Kiel, Arnold-Heller-Str. 3, Building U30, Entrance 1, 24105, Kiel, Germany.
Traulsen A; Department of Theoretical Biology, Max Planck Institute for Evolutionary Biology, August-Thienemann-Str. 2, 24306, Plön, Germany.
Raatz M; Department of Theoretical Biology, Max Planck Institute for Evolutionary Biology, August-Thienemann-Str. 2, 24306, Plön, Germany.
Pokaż więcej
Źródło:
NPJ systems biology and applications [NPJ Syst Biol Appl] 2023 Oct 06; Vol. 9 (1), pp. 48. Date of Electronic Publication: 2023 Oct 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Biological Evolution*
Neoplasms*/genetics
Humans ; Phenotype ; Models, Theoretical ; Adaptation, Physiological/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Combining Solid and Liquid Biopsy for Therapy Monitoring in Esophageal Cancer.
Autorzy:
Richter F; Department of General and Thoracic Surgery, University Hospital Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
Henssen C; Institute of Clinical Molecular Biology, Kiel University, 24105 Kiel, Germany.
Steiert TA; Institute of Clinical Molecular Biology, Kiel University, 24105 Kiel, Germany.
Meissner T; Department of Molecular and Experimental Medicine, Avera Cancer Institute, Sioux Falls, SD 57105, USA.
Mehdorn AS; Department of General and Thoracic Surgery, University Hospital Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
Röcken C; Department of Pathology, University Hospital Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
Franke A; Institute of Clinical Molecular Biology, Kiel University, 24105 Kiel, Germany.
Egberts JH; Department of Surgery, Israelitisches Krankenhaus Hamburg, 22297 Hamburg, Germany.
Becker T; Department of General and Thoracic Surgery, University Hospital Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
Sebens S; Institute for Experimental Cancer Research, Kiel University, University Hospital Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
Forster M; Institute of Clinical Molecular Biology, Kiel University, 24105 Kiel, Germany.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jun 26; Vol. 24 (13). Date of Electronic Publication: 2023 Jun 26.
Typ publikacji:
Journal Article
MeSH Terms:
Circulating Tumor DNA*/genetics
Esophageal Neoplasms*/diagnosis
Esophageal Neoplasms*/genetics
Humans ; Biomarkers, Tumor/genetics ; DNA, Neoplasm/genetics ; Liquid Biopsy ; Mutation ; Homeodomain Proteins/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Sequential Treatment with Temozolomide Plus Naturally Derived AT101 as an Alternative Therapeutic Strategy: Insights into Chemoresistance Mechanisms of Surviving Glioblastoma Cells.
Autorzy:
Hellmold D; Department of Neurosurgery, University Medical Center Schleswig-Holstein UKSH, Campus Kiel, 24105 Kiel, Germany.
Kubelt C; Department of Neurosurgery, University Medical Center Schleswig-Holstein UKSH, Campus Kiel, 24105 Kiel, Germany.
Daunke T; Institute of Experimental Cancer Research, University Medical Center Schleswig-Holstein UKSH, Campus Kiel, 24105 Kiel, Germany.
Beckinger S; Institute of Experimental Cancer Research, University Medical Center Schleswig-Holstein UKSH, Campus Kiel, 24105 Kiel, Germany.
Janssen O; Institute for Immunology, University Medical Center Schleswig-Holstein UKSH, Campus Kiel, 24105 Kiel, Germany.
Hauck M; Functional Nanomaterials, Department of Materials Science, Kiel University, 24143 Kiel, Germany.
Schütt F; Functional Nanomaterials, Department of Materials Science, Kiel University, 24143 Kiel, Germany.
Adelung R; Functional Nanomaterials, Department of Materials Science, Kiel University, 24143 Kiel, Germany.
Lucius R; Institute of Anatomy, Kiel University, 24098 Kiel, Germany.
Haag J; Department of Pathology, Kiel University, 24105 Kiel, Germany.
Sebens S; Institute of Experimental Cancer Research, University Medical Center Schleswig-Holstein UKSH, Campus Kiel, 24105 Kiel, Germany.
Synowitz M; Department of Neurosurgery, University Medical Center Schleswig-Holstein UKSH, Campus Kiel, 24105 Kiel, Germany.
Held-Feindt J; Department of Neurosurgery, University Medical Center Schleswig-Holstein UKSH, Campus Kiel, 24105 Kiel, Germany.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 May 22; Vol. 24 (10). Date of Electronic Publication: 2023 May 22.
Typ publikacji:
Journal Article
MeSH Terms:
Glioblastoma*/drug therapy
Glioblastoma*/genetics
Gossypol*/pharmacology
Brain Neoplasms*/drug therapy
Brain Neoplasms*/genetics
Humans ; Temozolomide/pharmacology ; Temozolomide/therapeutic use ; Drug Resistance, Neoplasm/genetics ; Cell Line, Tumor ; Neoplasm Recurrence, Local/drug therapy ; TOR Serine-Threonine Kinases ; Antineoplastic Agents, Alkylating/pharmacology ; Antineoplastic Agents, Alkylating/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo.
Autorzy:
Genduso S; Institute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
Freytag V; Institute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
Schetler D; Institute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
Kirchner L; Institute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
Schiecke A; Institute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
Maar H; Institute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.; Institute of Anatomy I, Cancer Center Central Germany, Jena University Hospital, Teichgraben 7, 07743, Jena, Germany.
Wicklein D; Institute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.; Department of Anatomy and Cell Biology, University of Marburg, Robert-Koch-Strasse 8, 35037, Marburg, Germany.
Gebauer F; Institute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Department of General, Visceral and Thoracic Surgery, University Hospital Cologne, Kerpener Strasse 62, 50937, Cologne, Germany.
Bröker K; Institute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
Stürken C; Institute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.; Faculty of Medicine, MSH Medical School Hamburg, Medical University, 20251, Hamburg, Germany.
Milde-Langosch K; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Oliveira-Ferrer L; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Ricklefs FL; Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Ewald F; Institute of Biochemistry and Signal Transduction, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Wolters-Eisfeld G; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Department of Pediatric Hematology and Oncology, Research Institute Childrens' Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Riecken K; Research Department Cell and Gene Therapy, Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Unrau L; Institue of Experimental Immunology and Hepatology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Krause L; Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Bohnenberger H; Institute of Pathology, University Medical Center Göttingen, Robert-Koch-Strasse 40, 37075, Göttingen, Germany.
Offermann A; Institute of Pathology, University of Lübeck and University Medical Center Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.
Perner S; Institute of Pathology, University of Lübeck and University Medical Center Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.
Sebens S; Institute for Experimental Cancer Research, Kiel University (CAU) and University Medical Center Schleswig-Holstein, Campus Kiel, Arnold-Heller-Strasse 3, 24105, Kiel, Germany.
Lamszus K; Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Diehl L; Institue of Experimental Immunology and Hepatology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Linder S; Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Jücker M; Institute of Biochemistry and Signal Transduction, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Schumacher U; Institute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.; Medical School Berlin, Leipziger Platz 10, 10117, Berlin, Germany.
Lange T; Institute of Anatomy and Experimental Morphology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany. .; Institute of Anatomy I, Cancer Center Central Germany, Jena University Hospital, Teichgraben 7, 07743, Jena, Germany. .
Pokaż więcej
Źródło:
Journal of hematology & oncology [J Hematol Oncol] 2023 Mar 17; Vol. 16 (1), pp. 23. Date of Electronic Publication: 2023 Mar 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Integrin beta4*/metabolism
Myeloid-Derived Suppressor Cells*
Neoplasms*
Animals ; Humans ; Mice ; Cell Line, Tumor ; Chemokines ; Endothelial Cells/metabolism ; P-Selectin ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Biomarkers in Liquid Biopsies for Prediction of Early Liver Metastases in Pancreatic Cancer.
Autorzy:
Mehdorn AS; Department of General, Visceral, Thoracic, Transplantation and Pediatric Surgery, University Hospital Schleswig-Holstein Campus Kiel, Arnold-Heller-Str. 3, Building C, 24105 Kiel, Germany.
Gemoll T; Section for Translational Surgical Oncology and Biobanking, Department of Surgery, University Medical Center Schleswig-Holstein, University of Lübeck, Campus Lübeck, Ratzeburger Allee 160, 23562 Lübeck, Germany.
Busch H; Group Medical Systems Biology, University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany.; Institute for Experimental Dermatology, University of Lübeck, Ratzeburger Allee 160, 23562 Lübeck, Germany.; Institute for Cardiogenetics, University of Lübeck, Building 67, Ratzeburger Allee 160, 23562 Lübeck, Germany.
Kern K; Section for Translational Surgical Oncology and Biobanking, Department of Surgery, University Medical Center Schleswig-Holstein, University of Lübeck, Campus Lübeck, Ratzeburger Allee 160, 23562 Lübeck, Germany.
Beckinger S; Institute for Experimental Cancer Research, University Hospital Schleswig-Holstein Campus Kiel, Kiel University, Arnold-Heller-Str. 3, Building U30 Entrance 1, 24105 Kiel, Germany.
Daunke T; Institute for Experimental Cancer Research, University Hospital Schleswig-Holstein Campus Kiel, Kiel University, Arnold-Heller-Str. 3, Building U30 Entrance 1, 24105 Kiel, Germany.
Kahlert C; Department for Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, Technical University Dresden, Building 59, Fetscherstraße 74, 01307 Dresden, Germany.
Uzunoglu FG; General, Visceral and Thoracic Surgery Department and Clinic, University Medical Center, Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
Hendricks A; Department of General, Thorax, Vascular and Transplant Surgery, University Hospital Rostock, Schillingallee 35, 18057 Rostock, Germany.
Buertin F; Department of General, Thorax, Vascular and Transplant Surgery, University Hospital Rostock, Schillingallee 35, 18057 Rostock, Germany.
Wittel UA; Department of General and Visceral Surgery, Centre of Surgery, Medical Centre, Faculty of Medicine, University of Freiburg, Breisacher Str. 86, 79110 Freiburg, Germany.
Sunami Y; Department of Visceral, Vascular and Endocrine Surgery, Martin-Luther-University Halle-Wittenberg University Medical Center Halle, Ernst-Grube-Straße 40, 06120 Halle, Germany.
Röcken C; Institute of Pathology, University Hospital Schleswig-Holstein Campus Kiel, Arnold-Heller-Str. 3, Building U33, 24105 Kiel, Germany.
Becker T; Department of General, Visceral, Thoracic, Transplantation and Pediatric Surgery, University Hospital Schleswig-Holstein Campus Kiel, Arnold-Heller-Str. 3, Building C, 24105 Kiel, Germany.
Sebens S; Institute for Experimental Cancer Research, University Hospital Schleswig-Holstein Campus Kiel, Kiel University, Arnold-Heller-Str. 3, Building U30 Entrance 1, 24105 Kiel, Germany.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Sep 22; Vol. 14 (19). Date of Electronic Publication: 2022 Sep 22.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Paracrine Interaction of Cholangiocellular Carcinoma with Cancer-Associated Fibroblasts and Schwann Cells Impact Cell Migration.
Autorzy:
Gundlach JP; Department of General, Visceral-, Thoracic-, Transplantation- and Pediatric Surgery, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Arnold-Heller-Str. 3, Building C, 24105 Kiel, Germany.; Institute for Experimental Cancer Research, Kiel University and University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Arnold-Heller-Str. 3, Building U30, 24105 Kiel, Germany.
Kerber J; Department of General, Visceral-, Thoracic-, Transplantation- and Pediatric Surgery, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Arnold-Heller-Str. 3, Building C, 24105 Kiel, Germany.; Institute for Experimental Cancer Research, Kiel University and University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Arnold-Heller-Str. 3, Building U30, 24105 Kiel, Germany.
Hendricks A; Department of General, Visceral-, Vascular-, and Transplantation Surgery, Medical University Rostock, Schillingallee 35, 18057 Rostock, Germany.
Bernsmeier A; Department of General, Visceral-, Thoracic-, Transplantation- and Pediatric Surgery, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Arnold-Heller-Str. 3, Building C, 24105 Kiel, Germany.
Halske C; Institute of Pathology, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Arnold-Heller-Str. 3, Building U33, 24105 Kiel, Germany.
Röder C; Institute for Experimental Cancer Research, Kiel University and University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Arnold-Heller-Str. 3, Building U30, 24105 Kiel, Germany.
Becker T; Department of General, Visceral-, Thoracic-, Transplantation- and Pediatric Surgery, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Arnold-Heller-Str. 3, Building C, 24105 Kiel, Germany.
Röcken C; Institute of Pathology, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Arnold-Heller-Str. 3, Building U33, 24105 Kiel, Germany.
Braun F; Department of General, Visceral-, Thoracic-, Transplantation- and Pediatric Surgery, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Arnold-Heller-Str. 3, Building C, 24105 Kiel, Germany.
Sebens S; Institute for Experimental Cancer Research, Kiel University and University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Arnold-Heller-Str. 3, Building U30, 24105 Kiel, Germany.
Heits N; Department of General, Visceral-, Thoracic-, Transplantation- and Pediatric Surgery, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Arnold-Heller-Str. 3, Building C, 24105 Kiel, Germany.; Gesundheitszentrum Kiel-Mitte, Prüner Gang 15, 24103 Kiel, Germany.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2022 May 15; Vol. 11 (10). Date of Electronic Publication: 2022 May 15.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Detection of Circulating and Disseminated Tumor Cells and Their Prognostic Value under the Influence of Neoadjuvant Therapy in Esophageal Cancer Patients.
Autorzy:
Richter F; Department of General, Visceral-, Thoracic-, Transplantation- and Pediatric Surgery, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, 24105 Kiel, Germany.
Röder C; Institute for Experimental Cancer Research, Kiel University (CAU) and University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, 24105 Kiel, Germany.
Möller T; Department of General, Visceral-, Thoracic-, Transplantation- and Pediatric Surgery, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, 24105 Kiel, Germany.
Egberts JH; Department of Surgery, Israelitisches Krankenhaus, 22297 Hamburg, Germany.
Becker T; Department of General, Visceral-, Thoracic-, Transplantation- and Pediatric Surgery, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, 24105 Kiel, Germany.
Sebens S; Institute for Experimental Cancer Research, Kiel University (CAU) and University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, 24105 Kiel, Germany.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Mar 01; Vol. 14 (5). Date of Electronic Publication: 2022 Mar 01.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Detection of Cancer Mutations by Urine Liquid Biopsy as a Potential Tool in the Clinical Management of Bladder Cancer Patients.
Autorzy:
Ibrahim NK; Department of Pediatric Hematology and Oncology, Hannover Medical School, 30625 Hanover, Germany.; Institute of Clinical Molecular Biology, Kiel University, 24105 Kiel, Germany.
Eraky A; Department of Urology, University Hospital Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
Eggers J; Department of Urology, University Hospital Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
Steiert TA; Institute of Clinical Molecular Biology, Kiel University, 24105 Kiel, Germany.
Sebens S; Institute for Experimental Cancer Research, Kiel University and University Hospital Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
Jünemann KP; Department of Urology, University Hospital Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
Hendricks A; Department of General Surgery, University Medicine Rostock, 18057 Rostock, Germany.
Bang C; Institute of Clinical Molecular Biology, Kiel University, 24105 Kiel, Germany.
Stanulla M; Department of Pediatric Hematology and Oncology, Hannover Medical School, 30625 Hanover, Germany.
Franke A; Institute of Clinical Molecular Biology, Kiel University, 24105 Kiel, Germany.
Hamann C; Department of Urology, University Hospital Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
Röcken C; Department of Pathology, University Hospital Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
Arnold N; Institute of Clinical Molecular Biology, Kiel University, 24105 Kiel, Germany.
Hinze L; Department of Pediatric Hematology and Oncology, Hannover Medical School, 30625 Hanover, Germany.
Forster M; Institute of Clinical Molecular Biology, Kiel University, 24105 Kiel, Germany.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Feb 15; Vol. 14 (4). Date of Electronic Publication: 2022 Feb 15.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Breaking the crosstalk of the Cellular Tumorigenic Network by low-dose combination therapy in lung cancer patient-derived xenografts.
Autorzy:
Gürgen D; EPO Experimental Pharmacology & Oncology, Berlin, Germany.
Conrad T; EPO Experimental Pharmacology & Oncology, Berlin, Germany.
Becker M; EPO Experimental Pharmacology & Oncology, Berlin, Germany.
Sebens S; Institute for Tumorbiology, University of Kiel, Kiel, Germany.
Röcken C; Institute for Pathology, University of Kiel, Kiel, Germany.
Hoffmann J; EPO Experimental Pharmacology & Oncology, Berlin, Germany.
Langhammer S; life science consulting, Burgwedel, Germany. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2022 Jan 17; Vol. 5 (1), pp. 59. Date of Electronic Publication: 2022 Jan 17.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Carcinoma, Non-Small-Cell Lung/*drug therapy
Lung Neoplasms/*drug therapy
Animals ; Female ; Heterografts ; Mice ; Mice, Nude
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Detection of Marker Associated with CTC in Colorectal Cancer in Mononuclear Cells of Patients with Benign Inflammatory Intestinal Diseases.
Autorzy:
Born J; Institute for Experimental Cancer Research, Kiel University and University Hospital Schleswig-Holstein Campus Kiel, Arnold-Heller-Str. 3, Building U30 Entrance 1, 24105 Kiel, Germany.
Hendricks A; Department of General, Visceral, Thoracic, Transplantation and Pediatric Surgery, University Hospital Schleswig-Holstein Campus Kiel, Arnold-Heller-Str. 3, Building C, 24105 Kiel, Germany.
Hauser C; Department of General, Visceral, Thoracic, Transplantation and Pediatric Surgery, University Hospital Schleswig-Holstein Campus Kiel, Arnold-Heller-Str. 3, Building C, 24105 Kiel, Germany.
Egberts JH; Department of General, Visceral, Thoracic, Transplantation and Pediatric Surgery, University Hospital Schleswig-Holstein Campus Kiel, Arnold-Heller-Str. 3, Building C, 24105 Kiel, Germany.
Becker T; Department of General, Visceral, Thoracic, Transplantation and Pediatric Surgery, University Hospital Schleswig-Holstein Campus Kiel, Arnold-Heller-Str. 3, Building C, 24105 Kiel, Germany.
Röder C; Institute for Experimental Cancer Research, Kiel University and University Hospital Schleswig-Holstein Campus Kiel, Arnold-Heller-Str. 3, Building U30 Entrance 1, 24105 Kiel, Germany.
Sebens S; Institute for Experimental Cancer Research, Kiel University and University Hospital Schleswig-Holstein Campus Kiel, Arnold-Heller-Str. 3, Building U30 Entrance 1, 24105 Kiel, Germany.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Dec 23; Vol. 14 (1). Date of Electronic Publication: 2021 Dec 23.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Insulin Receptor in Pancreatic Cancer-Crown Witness in Cross Examination.
Autorzy:
Heckl SM; Department of Internal Medicine I, University Hospital Schleswig-Holstein, 24105 Kiel, Germany.; Department of Pathology, Christian-Albrechts-University Kiel, 24105 Kiel, Germany.; Department of Internal Medicine II, University Hospital Schleswig-Holstein, 24105 Kiel, Germany.
Kercher L; Department of Pathology, Christian-Albrechts-University Kiel, 24105 Kiel, Germany.
Abdullazade S; Department of Pathology, Christian-Albrechts-University Kiel, 24105 Kiel, Germany.
Schneider C; Department of Pathology, Christian-Albrechts-University Kiel, 24105 Kiel, Germany.
Krüger S; Department of Pathology, Christian-Albrechts-University Kiel, 24105 Kiel, Germany.
Behrens HM; Department of Pathology, Christian-Albrechts-University Kiel, 24105 Kiel, Germany.
Sebens S; Institute for Experimental Cancer Research, Christian-Albrechts-University Kiel, 24105 Kiel, Germany.
Schäfer H; Department of Internal Medicine I, University Hospital Schleswig-Holstein, 24105 Kiel, Germany.; Institute for Experimental Cancer Research, Christian-Albrechts-University Kiel, 24105 Kiel, Germany.
Schreiber S; Department of Internal Medicine I, University Hospital Schleswig-Holstein, 24105 Kiel, Germany.
Röcken C; Department of Pathology, Christian-Albrechts-University Kiel, 24105 Kiel, Germany.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Oct 05; Vol. 13 (19). Date of Electronic Publication: 2021 Oct 05.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Heterogeneity of the Tumor Microenvironment as Essential Determinant of Development, Progression and Therapy Response of Pancreatic Cancer.
Autorzy:
Group Young Researchers In Inflammatory Carcinogenesis; Institute for Experimental Cancer Research, Kiel University and University Hospital Schleswig-Holstein Campus Kiel, Arnold-Heller-Str. 3, Building U30 Entrance 1, 24105 Kiel, Germany.
Wandmacher AM; Department of Internal Medicine II, University Hospital Schleswig-Holstein Campus Kiel, Arnold-Heller-Str. 3, 24105 Kiel, Germany.
Mehdorn AS; Department of General, Visceral, Thoracic, Transplantation and Pediatric Surgery, University Hospital Schleswig-Holstein Campus Kiel, Arnold-Heller-Str. 3, Building C, 24105 Kiel, Germany.
Sebens S; Institute for Experimental Cancer Research, Kiel University and University Hospital Schleswig-Holstein Campus Kiel, Arnold-Heller-Str. 3, Building U30 Entrance 1, 24105 Kiel, Germany.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Sep 30; Vol. 13 (19). Date of Electronic Publication: 2021 Sep 30.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Challenges and Future Perspectives of Immunotherapy in Pancreatic Cancer.
Autorzy:
Wandmacher AM; Department of Internal Medicine II, University Medical Center Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany.; Institute for Experimental Cancer Research, Kiel University and University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany.
Letsch A; Department of Internal Medicine II, University Medical Center Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany.
Sebens S; Institute for Experimental Cancer Research, Kiel University and University Hospital Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Aug 23; Vol. 13 (16). Date of Electronic Publication: 2021 Aug 23.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Initiation of Pancreatic Cancer: The Interplay of Hyperglycemia and Macrophages Promotes the Acquisition of Malignancy-Associated Properties in Pancreatic Ductal Epithelial Cells.
Autorzy:
Otto L; Institute for Experimental Cancer Research, Kiel University (CAU) and University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, 24105 Kiel, Germany.
Rahn S; Institute of Biochemistry, Kiel University, 24118 Kiel, Germany.
Daunke T; Institute for Experimental Cancer Research, Kiel University (CAU) and University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, 24105 Kiel, Germany.
Walter F; Institute for Experimental Cancer Research, Kiel University (CAU) and University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, 24105 Kiel, Germany.
Winter E; Institute for Experimental Cancer Research, Kiel University (CAU) and University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, 24105 Kiel, Germany.
Möller JL; Department of Hematology and Oncology, University Medical Center Schleswig-Holstein (UKSH) Campus Kiel, 24105 Kiel, Germany.
Rose-John S; Institute of Biochemistry, Kiel University, 24118 Kiel, Germany.
Wesch D; Institute of Immunology, Kiel University and University Medical Center Schleswig-Holstein (UKSH) Campus Kiel, 24105 Kiel, Germany.
Schäfer H; Institute for Experimental Cancer Research, Kiel University (CAU) and University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, 24105 Kiel, Germany.
Sebens S; Institute for Experimental Cancer Research, Kiel University (CAU) and University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, 24105 Kiel, Germany.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 May 11; Vol. 22 (10). Date of Electronic Publication: 2021 May 11.
Typ publikacji:
Journal Article
MeSH Terms:
Epithelial-Mesenchymal Transition*
Gene Expression Regulation, Neoplastic*
Carcinoma, Pancreatic Ductal/*pathology
Epithelial Cells/*pathology
Hyperglycemia/*complications
Macrophages/*immunology
Pancreatic Neoplasms/*pathology
Carcinoma, Pancreatic Ductal/etiology ; Carcinoma, Pancreatic Ductal/metabolism ; Cell Movement ; Cell Proliferation ; Coculture Techniques ; Diabetes Mellitus, Type 2/physiopathology ; Epithelial Cells/metabolism ; Humans ; Pancreatic Neoplasms/etiology ; Pancreatic Neoplasms/metabolism ; Signal Transduction
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
ADAM17 Inhibition Increases the Impact of Cisplatin Treatment in Ovarian Cancer Spheroids.
Autorzy:
Hedemann N; Department of Gynecology and Obstetrics, Kiel University and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
Herz A; Department of Gynecology and Obstetrics, Kiel University and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
Schiepanski JH; Department of Gynecology and Obstetrics, Kiel University and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
Dittrich J; Department of Gynecology and Obstetrics, Kiel University and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
Sebens S; Institute for Experimental Cancer Research, Kiel University and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
Dempfle A; Institute of Medical Informatics and Statistics, Kiel University and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
Feuerborn J; Department of Gynecology and Obstetrics, Kiel University and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
Rogmans C; Department of Gynecology and Obstetrics, Kiel University and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
Tribian N; Department of Gynecology and Obstetrics, Kiel University and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
Flörkemeier I; Department of Gynecology and Obstetrics, Kiel University and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
Weimer J; Department of Gynecology and Obstetrics, Kiel University and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
Krüger S; Department of Pathology, Kiel University and University Medical Center, Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
Maass N; Department of Gynecology and Obstetrics, Kiel University and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
Bauerschlag DO; Department of Gynecology and Obstetrics, Kiel University and University Medical Center Schleswig-Holstein Campus Kiel, 24105 Kiel, Germany.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Apr 23; Vol. 13 (9). Date of Electronic Publication: 2021 Apr 23.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Chitosan nanoparticles as antigen vehicles to induce effective tumor specific T cell responses.
Autorzy:
Walter F; Institute for Experimental Cancer Research, Kiel University and University Medical Center Schleswig-Holstein (UKSH) Campus Kiel, Kiel, Germany.
Winter E; Institute for Experimental Cancer Research, Kiel University and University Medical Center Schleswig-Holstein (UKSH) Campus Kiel, Kiel, Germany.
Rahn S; Institute of Biochemistry, Kiel University, Kiel, Germany.
Heidland J; Department of Pharmaceutics and Biopharmaceutics, Kiel University, Kiel, Germany.
Meier S; Department of Pharmaceutics and Biopharmaceutics, Kiel University, Kiel, Germany.
Struzek AM; Department of Pharmaceutics and Biopharmaceutics, Kiel University, Kiel, Germany.
Lettau M; Institute of Immunology, Kiel University and UKSH Campus Kiel, Kiel, Germany.
Philipp LM; Institute for Experimental Cancer Research, Kiel University and University Medical Center Schleswig-Holstein (UKSH) Campus Kiel, Kiel, Germany.
Beckinger S; Institute for Experimental Cancer Research, Kiel University and University Medical Center Schleswig-Holstein (UKSH) Campus Kiel, Kiel, Germany.
Otto L; Institute for Experimental Cancer Research, Kiel University and University Medical Center Schleswig-Holstein (UKSH) Campus Kiel, Kiel, Germany.
Möller JL; Department of Hematology and Oncology, University Medical Center Schleswig-Holstein (UKSH) Campus Kiel, Kiel, Germany.
Helm O; Institute for Experimental Cancer Research, Kiel University and University Medical Center Schleswig-Holstein (UKSH) Campus Kiel, Kiel, Germany.
Wesch D; Institute of Immunology, Kiel University and UKSH Campus Kiel, Kiel, Germany.
Scherließ R; Department of Pharmaceutics and Biopharmaceutics, Kiel University, Kiel, Germany.
Sebens S; Institute for Experimental Cancer Research, Kiel University and University Medical Center Schleswig-Holstein (UKSH) Campus Kiel, Kiel, Germany.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Sep 30; Vol. 15 (9), pp. e0239369. Date of Electronic Publication: 2020 Sep 30 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antigens, Neoplasm/*chemistry
Antigens, Neoplasm/*immunology
CD8-Positive T-Lymphocytes/*immunology
Chitosan/*chemistry
Drug Carriers/*chemistry
Nanoparticles/*chemistry
Animals ; CD8-Positive T-Lymphocytes/cytology ; Cell Line ; Coculture Techniques ; Dendritic Cells/cytology ; Dendritic Cells/immunology ; Humans ; Mice ; Phenotype ; Vaccination
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Isolation and Enumeration of CTC in Colorectal Cancer Patients: Introduction of a Novel Cell Imaging Approach and Comparison to Cellular and Molecular Detection Techniques.
Autorzy:
Hendricks A; Department of General, Visceral, Thoracic, Transplantation and Pediatric Surgery, University Hospital Schleswig-Holstein Campus Kiel, Arnold-Heller-Str. 3, Building C, 24105 Kiel, Germany.
Brandt B; Institute of Clinical Chemistry, University Hospital Schleswig-Holstein Campus Kiel, Arnold-Heller-Str. 3, Building U30, 24105 Kiel, Germany.
Geisen R; ORGA Labormanagement GmbH, Hospitalstraße 2, 48607 Ochtrup, Germany.
Dall K; Department of General, Visceral, Thoracic, Transplantation and Pediatric Surgery, University Hospital Schleswig-Holstein Campus Kiel, Arnold-Heller-Str. 3, Building C, 24105 Kiel, Germany.
Röder C; Institute for Experimental Cancer Research, Kiel University and University Hospital Schleswig-Holstein Campus Kiel, Arnold-Heller-Str. 3, Building U30 Entrance 1, 24105 Kiel, Germany.
Schafmayer C; Department of General, Visceral, Thoracic, Transplantation and Pediatric Surgery, University Hospital Schleswig-Holstein Campus Kiel, Arnold-Heller-Str. 3, Building C, 24105 Kiel, Germany.
Becker T; Department of General, Visceral, Thoracic, Transplantation and Pediatric Surgery, University Hospital Schleswig-Holstein Campus Kiel, Arnold-Heller-Str. 3, Building C, 24105 Kiel, Germany.
Hinz S; Department of General, Visceral, Thoracic, Transplantation and Pediatric Surgery, University Hospital Schleswig-Holstein Campus Kiel, Arnold-Heller-Str. 3, Building C, 24105 Kiel, Germany.
Sebens S; Institute for Experimental Cancer Research, Kiel University and University Hospital Schleswig-Holstein Campus Kiel, Arnold-Heller-Str. 3, Building U30 Entrance 1, 24105 Kiel, Germany.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2020 Sep 16; Vol. 12 (9). Date of Electronic Publication: 2020 Sep 16.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comparative Analysis of Blood and Bone Marrow for the Detection of Circulating and Disseminated Tumor Cells and Their Prognostic and Predictive Value in Esophageal Cancer Patients.
Autorzy:
Richter F; Department of General, Visceral-, Thoracic-, Transplantation- and Pediatric Surgery, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, 24105 Kiel, Germany.
Baratay A; Institute for Experimental Cancer Research, Kiel University (CAU) and University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, 24105 Kiel, Germany.
Röder C; Institute for Experimental Cancer Research, Kiel University (CAU) and University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, 24105 Kiel, Germany.
Egberts JH; Department of General, Visceral-, Thoracic-, Transplantation- and Pediatric Surgery, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, 24105 Kiel, Germany.
Kalthoff H; Institute for Experimental Cancer Research, Kiel University (CAU) and University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, 24105 Kiel, Germany.
Becker T; Department of General, Visceral-, Thoracic-, Transplantation- and Pediatric Surgery, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, 24105 Kiel, Germany.
Sebens S; Institute for Experimental Cancer Research, Kiel University (CAU) and University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, 24105 Kiel, Germany.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2020 Aug 18; Vol. 9 (8). Date of Electronic Publication: 2020 Aug 18.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Impact of the Monocarboxylate Transporter-1 (MCT1)-Mediated Cellular Import of Lactate on Stemness Properties of Human Pancreatic Adenocarcinoma Cells †.
Autorzy:
Sandforth L; Institute for Experimental Cancer Research-Christian-Albrechts-University & UKSH Campus Kiel-Bldg. U30, Arnold-Heller-Straße 3, 24105 Kiel, Germany.
Ammar N; Institute for Experimental Cancer Research-Christian-Albrechts-University & UKSH Campus Kiel-Bldg. U30, Arnold-Heller-Straße 3, 24105 Kiel, Germany.
Dinges LA; Institute for Experimental Cancer Research-Christian-Albrechts-University & UKSH Campus Kiel-Bldg. U30, Arnold-Heller-Straße 3, 24105 Kiel, Germany.
Röcken C; Department of Pathology - Christian-Albrechts-University & UKSH Campus Kiel-Bldg. U33, Arnold-Heller-Straße 3, 24105 Kiel, Germany.; Biomaterial Bank of the Comprehensive Cancer Center Kiel - UKSH Campus Kiel-Bldg. 17, Arnold-Heller-Straße 3, 24105 Kiel, Germany.
Arlt A; Department of Internal Medicine I-UKSH Campus Kiel-Bldg. K3, Arnold-Heller-Straße 3, 24105 Kiel, Germany.
Sebens S; Institute for Experimental Cancer Research-Christian-Albrechts-University & UKSH Campus Kiel-Bldg. U30, Arnold-Heller-Straße 3, 24105 Kiel, Germany.; Biomaterial Bank of the Comprehensive Cancer Center Kiel - UKSH Campus Kiel-Bldg. 17, Arnold-Heller-Straße 3, 24105 Kiel, Germany.
Schäfer H; Institute for Experimental Cancer Research-Christian-Albrechts-University & UKSH Campus Kiel-Bldg. U30, Arnold-Heller-Straße 3, 24105 Kiel, Germany.; Department of Internal Medicine I-UKSH Campus Kiel-Bldg. K3, Arnold-Heller-Straße 3, 24105 Kiel, Germany.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2020 Mar 03; Vol. 12 (3). Date of Electronic Publication: 2020 Mar 03.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 38

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies